Clinical Trials
106 trialsA Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
Eisai Inc.
ELECTRA
Stemline Therapeutics, Inc.
PIKALO-1
Eli Lilly and Company
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Iambic Therapeutics, Inc
BASECAMP-1
A2 Biotherapeutics Inc.
Behavioral Pain Intervention for Older Cancer Patients
Duke University
Collection of Blood From Patients With Cancer
National Institutes of Health Clinical Center (CC)
Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced Neuropathic Pain
Dogwood Therapeutics Inc.
A Phase 1 Study of IM-1617 in Participants With Advanced Cancer
Immunome, Inc.
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
AstraZeneca
FOCUS
Ohio State University Comprehensive Cancer Center
The Sarah Nanotechnology System for Treatment of Advanced Metastatic Solid Tumors Using Hyperthermia.
New Phase Ltd.
Adaptive Symptom Self-Management Immunotherapy Study
University of Arizona
OP-NEU-101
Onchilles Pharma Inc
LONGEVITI
University of Alberta
A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials
University of Florida
A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer
Cancer Research UK
Pilot Study of [68Ga]Ga-ABY-025 Imaging in Patients Undergoing Treatment With HER2-targeted Therapy
Vanderbilt-Ingram Cancer Center
Repeat Breast Conserving Surgery Followed by Daily Partial Breast Irradiation in Ipsilateral Breast
Case Comprehensive Cancer Center
I-SPY
QuantumLeap Healthcare Collaborative
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Ensem Therapeutics
Mainstreaming Genetics: Evaluation of a Digital Application to Scale and Spread Oncologist-initiated Genetic Testing
Unity Health Toronto
AxeCan
HealthPartners Institute
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Stanford University
CHEMOVES
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
CER
Cancer Support Community, Research and Training Institute, Philadelphia
PERTUREAL
Société Algérienne de Formation et Recherche en Oncologie
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
National Institutes of Health Clinical Center (CC)
ReRT
The New York Proton Center
BRIA-ABC
BriaCell Therapeutics Corporation
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
Conjupro Biotherapeutics, Inc.
A Study of MOv18 IgE in Patients With Solid Tumours That Express Folate Receptor Alpha
Epsilogen Ltd
SURGE
Colorado State University
ASAP
Avera McKennan Hospital & University Health Center
ML-CardioTox
University Hospital, Caen
SAHARA-04
Institut du Cancer de Montpellier - Val d'Aurelle
RESOLBE
Clinica Universidad de Navarra, Universidad de Navarra
NEOPRO-SIT
University Hospital Muenster
MOMENTUM
UMC Utrecht
Predicting Response to Neoadjuvant Endocrine Therapy (Neo-PREDICT)
George Washington University
Psilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment Disorder
Psyence Australia Pty Ltd
IDOV-Immune for Advanced Solid Tumors
ViroMissile, Inc.
H3RAKLES
Institut Curie
The Florida ASCENT Study
University of Florida
Cognitive Rehabilitation Following Breast Cancer Treatment
University of Missouri-Columbia
TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers
Tizona Therapeutics, Inc
SELECT-CAR-NK
Essen Biotech
EBNK-ST-001
Essen Biotech
MAGNETO
Centre Leon Berard
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
Angiex, Inc.